Get to Know EktaH: New therapeutic solutions to combat overweight and obesity
Get to Know EktaH: New therapeutic solutions to combat overweight and obesity
EktaH, founded in 2021 from the University of Bourgogne's Nutrition and Toxicology Department, leverages 15+ years of lipid metabolism research. The company develops therapies targeting fat taste receptors to improve hormonal regulation, addressing obesity's root causes and promoting healthier eating habits.
This session is tailored for doctors, researchers, investors, and healthcare enthusiasts, offering a deep dive into EktaH's innovative approach to obesity treatment and its potential to reshape metabolic health.
Explore the details: https://capitalcell.com/en/campaign/ektah/
What will we cover in these sessions?
What is EktaH?
Discover the team behind EktaH, their mission, current progress, and future plans.
Why is this project so relevant?
Professor Naim Khan, Chief Scientific Officer at EktaH, and Xavier Boidevezi, CEO and former marketing expert at Danone and SEB, bring a powerful blend of scientific innovation and strategic vision. Professor Khan, a renowned researcher at the University of Bourgogne and recipient of the 2020 Academy of Medicine award for his pioneering work on lipid taste receptors, drives EktaH’s cutting-edge science. Xavier Boidevezi, with over a decade of experience in global brand strategy, ensures a clear path from lab to market. Together, they will present EktaH’s groundbreaking approach to obesity treatment and answer your questions, showcasing the science and strategy behind their innovation.
Q&A Session
Get answers to your questions about Capital Cell, how it works, and how you can be part of this journey.
Spread the Word
Share this webinar with your network to help advance the future of tissue transplants. See you soon!